BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan N, Patel D, Xie D, Pernes T, Lewis J, Yang YX. Adherence of Infusible Biologics During the Time of COVID-19 Among Patients With Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study. Gastroenterology 2020;159:1592-1594.e1. [PMID: 32574622 DOI: 10.1053/j.gastro.2020.06.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Barnes A, Andrews J, Spizzo P, Mountifield R. Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic. JGH Open 2021;5:585-9. [PMID: 34013059 DOI: 10.1002/jgh3.12537] [Reference Citation Analysis]
2 Wong GL, Yip TC, Wong VW, Tse YK, Hui DS, Lee SS, Yeoh EK, Chan HL, Lui GC. SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19. Open Forum Infect Dis 2021;8:ofab205. [PMID: 34099979 DOI: 10.1093/ofid/ofab205] [Reference Citation Analysis]
3 Khorshid M, AbdAllah M. Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic". Inflamm Bowel Dis 2021;27:e39. [PMID: 33512472 DOI: 10.1093/ibd/izaa355] [Reference Citation Analysis]
4 Tripathi K, Godoy Brewer G, Thu Nguyen M, Singh Y, Saleh Ismail M, Sauk JS, Parian AM, Limketkai BN. COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. Inflamm Bowel Dis 2021:izab236. [PMID: 34718595 DOI: 10.1093/ibd/izab236] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Barberio B, Zingone F, Bertani L, Savarino E. The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem? Gastroenterology 2021;160:1903-4. [PMID: 32687929 DOI: 10.1053/j.gastro.2020.07.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Norsa L, Cosimo P, Indriolo A, Sansotta N, D'Antiga L, Callegaro A. Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Under Biologic Treatment.Gastroenterology. 2020;159:2229-2231.e2. [PMID: 32860790 DOI: 10.1053/j.gastro.2020.08.046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
7 Bertani L, Barberio B, Tricò D, Zanzi F, Maniero D, Ceccarelli L, Marsilio I, Coppini F, Lorenzon G, Mumolo MG, Zingone F, Costa F, Savarino EV. Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak. J Clin Med 2021;10:3270. [PMID: 34362053 DOI: 10.3390/jcm10153270] [Reference Citation Analysis]